CogniCurrent

COGNICURRENT

Feb 5 • 16:10 UTC • 🇩🇰 Denmark • Politiken

Novo Nordisk strongly criticizes competitor

Novo Nordisk has issued a sharp condemnation of Hims and Hers for planning to launch a copy of the weight loss drug Wegovy, labeling it as illegal mass production that jeopardizes patient safety, and announcing intentions to take legal and regulatory action.

#pharmaceuticals #wegovy #competition #hims and hers #patient safety
Read Original Back to Feed

📡 Similar Coverage